859 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
2 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
3 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
4 Recruiting Proton Beam Radiation Therapy in Treating Patients With Recurrent Thoracic Cancer Who Have Received Prior Radiation Therapy
Conditions: Lung Metastases;   Recurrent Malignant Mesothelioma;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Recurrent Thymoma and Thymic Carcinoma
Intervention: Radiation: proton beam radiation therapy
5 Recruiting Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours
Condition: Non Small Cell Lung Cancer
Intervention: Drug: AZD9291
6 Unknown  Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gemcitabine and Docetaxel
7 Recruiting A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy Treatment.
Condition: Non-Small Cell Lung Cancer
Intervention:
8 Recruiting A Phase 1 Safety Study of Intradermal ID-LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1
Conditions: Breast Cancer;   Melanoma;   Non-small Cell Lung Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Biological: ID-LV305
9 Recruiting Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Condition: Small Cell Lung Carcinoma
Interventions: Biological: Ipilimumab;   Biological: Placebo matching Ipilimumab;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Carboplatin
10 Not yet recruiting Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Non-small-cell Lung Carcinoma;   Lung Cancer;   NSCLC
Interventions: Biological: gp96-Ig Vaccine;   Drug: Theophylline;   Other: Oxygen;   Procedure: Immunologic Evaluation
11 Recruiting A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: MEDI4736;   Other: PLACEBO
12 Recruiting Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression
Condition: Non Small Cell Lung Cancer
Interventions: Drug: EGFR tyrosine kinase inhibitor;   Drug: EGFR tyrosine kinase inhibitor with chemotherapy
13 Not yet recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
14 Recruiting Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Dacomitinib, Pemetrexed
15 Recruiting Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: celecoxib;   Drug: Docetaxel;   Drug: pemetrexed disodium;   Other: laboratory biomarker analysis
16 Not yet recruiting A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: RO5479599;   Drug: carboplatin;   Drug: paclitaxel
17 Recruiting Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in Non Small Cell Lung Cancer Patients
Condition: Non Small Cell Lung Cancer
Intervention: Drug: HM61713
18 Recruiting A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Bevacizumab;   Drug: Paclitaxel;   Drug: Carboplatin
19 Recruiting Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer
Intervention: Other: concurrent chemo-radiotherapy arm
20 Recruiting Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Conditions: Brain Metastases;   Non-small Cell Lung Cancer
Intervention: Drug: Lucanthone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years